OptimumBank Holdings, Inc.
OPHC NYSE National Commercial Banks Financials FY2016βFY2025
What OptimumBank Holdings, Inc. does
No business description yet.
- Legal name
- OptimumBank Holdings, Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Feb 26, 2026
- Accession Β· CIK
- 0001493152-26-008143
0001288855
Revenue and margins
OptimumBank Holdings, Inc. had $49.4M of revenue in fiscal 2025, up 25.6% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns and efficiency
For banks, return on equity and the efficiency ratio (costs as a share of revenue) say most about how well the business runs.
Dividends, buybacks and share count
OptimumBank Holdings, Inc. returned β to shareholders in fiscal 2025. The diluted share count rose 23.8%.
Balance sheet
Loans, deposits and capital at each fiscal year end.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Loans, net | $248M | $477M | β | β | β |
| Deposits | $292M | $508M | $640M | $772M | $932M |
| Loans / deposits | 84.8% | 94.0% | β | β | β |
| Total assets | $352M | $585M | $791M | $933M | $1.1B |
| Shareholders' equity | $38.5M | $62.6M | $70.0M | $103M | $122M |
| Provision / loans | 0.5% | 0.7% | β | β | β |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $3.5M | $3.6M | $3.1M | $3.3M | $5.3M | $11.2M | $18.8M | $27.2M | $39.3M | $49.4M |
| Net interest income | $3.7M | $3.5M | $3.0M | $3.1M | $5.0M | $9.4M | $15.8M | $23.7M | $34.7M | $42.6M |
| Noninterest income | β$0.1M | $0.1M | $0.1M | $0.2M | $0.3M | $1.8M | $3.0M | $3.5M | $4.6M | $6.8M |
| Noninterest expense | $3.9M | $4.2M | $4.1M | $4.5M | $5.0M | $6.9M | $9.9M | $14.7M | $19.5M | $25.2M |
| Provision for credit losses | β | β | β$1.8M | β$0.1M | $1.0M | $1.2M | $3.5M | $3.8M | $2.4M | $1.9M |
| Interest expense | $1.1M | $1.2M | $1.2M | $2.0M | $1.7M | $1.0M | $4.0M | $12.1M | β | β |
| Pretax income | β$0.4M | β$0.6M | $0.8M | β$1.2M | β$0.8M | $3.1M | $5.4M | $8.5M | $17.6M | $22.2M |
| Income tax | β | $0.1M | β$0.1M | β$0.1M | β | β$3.2M | $1.4M | $2.2M | $4.5M | $5.5M |
| Net income | β$0.4M | β$0.6M | $0.8M | β$1.1M | β$0.8M | $6.3M | $4.0M | $6.3M | $13.1M | $16.6M |
| Diluted EPS | β$0.38 | β$0.53 | $0.53 | β$0.58 | β$0.27 | $1.61 | $0.68 | $0.87 | $0.63 | $0.71 |
| Diluted shares | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.01B | 7.24B | 0.01B | 0.01B |
| Cash flow | ||||||||||
| Cash from operations | $0.6M | $0.6M | $0.0M | β$0.6M | β$1.5M | $3.8M | $10.4M | $6.9M | $15.6M | $17.8M |
| Capital expenditure | $0.1M | $0.1M | $0.2M | $0.5M | $0.2M | $0.4M | $0.3M | $0.7M | $1.0M | $0.9M |
| Free cash flow | $0.5M | $0.5M | β$0.2M | β$1.1M | β$1.7M | $3.4M | $10.0M | $6.2M | $14.6M | $16.9M |
| Depreciation and amortization | $0.2M | $0.1M | $0.2M | $0.2M | $0.2M | $0.2M | $0.2M | $0.2M | $0.3M | $0.5M |
| Stock-based compensation | $0.0M | $0.0M | β | $0.2M | $0.2M | $0.2M | $0.4M | $0.5M | $0.5M | $0.9M |
| Balance sheet | ||||||||||
| Loans, net | $77.0M | $68.2M | $77.2M | $102M | $152M | $248M | $477M | β | β | β |
| Deposits | $86.1M | $65.3M | $62.4M | $101M | $191M | $292M | $508M | $640M | $772M | $932M |
| Property and equipment, net | $2.6M | $2.6M | $2.7M | $1.4M | $1.4M | $0.8M | $0.9M | $1.4M | $2.1M | $2.5M |
| Total assets | $120M | $95.9M | $99.5M | $127M | $235M | $352M | $585M | $791M | $933M | $1.1B |
| Total liabilities | $117M | $93.3M | $94.1M | $120M | $217M | $313M | $523M | $721M | $830M | $990M |
| Shareholders' equity | $3.1M | $2.5M | $5.3M | $7.2M | $17.8M | $38.5M | $62.6M | $70.0M | $103M | $122M |
| Margins | ||||||||||
| Net margin | β11.2% | β16.5% | 25.4% | β33.2% | β14.8% | 56.3% | 21.4% | 23.1% | 33.4% | 33.7% |
| FCF margin | 12.7% | 13.3% | β6.7% | β32.2% | β31.4% | 30.3% | 53.4% | 22.9% | 37.2% | 34.3% |
| Net interest share of revenue | 104.1% | 98.5% | 97.3% | 94.5% | 94.4% | 84.1% | 84.3% | 87.3% | 88.2% | 86.3% |
| Efficiency ratio | 111.2% | 116.5% | 130.6% | 137.2% | 95.5% | 62.1% | 52.9% | 54.0% | 49.5% | 51.0% |
| Returns | ||||||||||
| Return on equity | β12.9% | β20.9% | 20.3% | β17.6% | β6.2% | 22.3% | 8.0% | 9.5% | 15.2% | 14.8% |
| Return on assets | β0.3% | β0.5% | 0.8% | β1.0% | β0.4% | 2.1% | 0.9% | 0.9% | 1.5% | 1.6% |
| Return on tangible equity | β12.9% | β23.1% | 15.0% | β15.3% | β4.4% | 16.3% | 6.4% | 9.0% | 12.7% | 13.7% |
| Growth | ||||||||||
| Revenue growth | β | 0.9% | β12.4% | 5.8% | 59.6% | 111.5% | 68.2% | 44.5% | 44.7% | 25.6% |
| Net income growth | β | β | β | β238.2% | β | β | β36.1% | 56.2% | 108.9% | 26.9% |
| EPS growth | β | β | β | β209.4% | β | β | β57.8% | 27.9% | β27.6% | 12.7% |
| FCF growth | β | 5.8% | β144.1% | β | β | β | 196.8% | β38.1% | 135.2% | 15.9% |
| Share count change | β | 6.1% | 35.1% | 27.4% | 54.3% | 32.9% | 52.7% | 121,460.4% | β99.9% | 23.8% |
| Financial health | ||||||||||
| Loans / deposits | 89.4% | 104.6% | 123.8% | 100.8% | 79.9% | 84.8% | 94.0% | β | β | β |
| Provision / loans | β | β | β2.3% | β0.1% | 0.7% | 0.5% | 0.7% | β | β | β |
| Capital allocation | ||||||||||
| Capex / revenue | 2.9% | 2.6% | 7.5% | 15.4% | 3.8% | 3.4% | 1.7% | 2.5% | 2.5% | 1.8% |
| Stock comp / revenue | 1.3% | 0.6% | β | 6.1% | 4.1% | 1.8% | 2.0% | 1.8% | 1.2% | 1.8% |
| Quality scores | ||||||||||
| Accruals ratio | β0.8% | β1.1% | 0.8% | β0.5% | 0.4% | 0.9% | β1.4% | β0.1% | β0.3% | β0.1% |
Source: SEC EDGAR XBRL filings (CIK 0001288855). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.